Obesity as a risk factor of in-hospital outcomes in patients with endometrial cancer treated with traditional surgical mode
Abstract
Objectives: Abdominal obesity is a risk factor for endometrial cancer. The negative impact of individual parameters of obesity on the procedural effects of endometrial cancer surgical treatment has been suggested. The aim of the current study was to estimate the relationship of particular parameters of obesity and in-hospital outcomes in patients treated surgically due to endometrial cancer. Material and methods: The study included 70 women treated surgically for endometrial cancer. Pre-operatively, mass, body mass index (BMI), waist circumference, waist-hip ratio and selected anatomical indices were measured. The duration of surgery, hospitalisation, and the loss of haemoglobin served as parameters of in-hospital procedure success. Also, procedural-related complications were estimated. Results: There were 37 (52.8%) obese females in the current study. They were obese patients presenting more advanced clinical stages of endometrial cancer before operation. The duration of operation (94.9 ± 21.6 min. vs. 76.1 ± 13.5 min., p < 0.0001), hospitalisation (12.4 ± 3.4 days vs. 10 ± 2.3 days, p = 0.0009) and haemoglobin loss (2.5 ± 0.9 g/dL vs. 1.9 ± 0.8 g/dL, p = 0.004) were significantly greater in obese patients. Multivariate analysis, among the independent predictors of the duration of operation, has confirmed the correlation between BMI, waist circumference and weight and the duration of hospitalisation. Waist and hip circumference and BMI coupled with external conjugate dimension and intertrochanteric distance have been linked with haemoglobin loss. The strongest correlation for the duration of operation, hospitalisation and haemoglobin loss was noticed for waist circumference (r = 0.7, r = 0.57 and r = 0.59). Conclusions: Waist circumference and BMI are strong predictors of in-hospital outcomes among patients with endometrial cancer treated via traditional surgical operation.
Keywords: abdominal obesityBMIcancer of endometriumoperative timeperioperative outcomes
References
- Zwierko M, Bidziński M. Nowotwory trzonu macicy. Centrum Medyczne Kształcenia Podyplomowego, Warszawa 2011: 5–27.
- Stewart B. World Cancer Report © International Agency for Research on Cancer. 2008; 5: 428–430.
- Abacjew-Chmyłk AO, Chmyłko Ł, Wydra DG, et al. Multiple multiparity is a negative prognostic factor for endometrial cancer in Poland. Ginekol Pol. 2016; 87(3): 178–182.
- Bręborowicz GH. Położnictwo i Ginekologia. Wydawnictwo Lekarskie PZWL Warszawa 2007: 833–842.
- Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612): 569–578.
- von Gruenigen VE, Tian C, Frasure H, et al. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study. Cancer. 2006; 107(12): 2786–2791.
- Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983; 15(1): 10–17.
- Roguz S, Krowiranda KW, Michalski T, et al. [Histological grading of endometrial carcinoma. Clinical and patomorphological analysis]. Ginekol Pol. 2015; 86(5): 340–345.
- Möllerström G, Carlström K, Lagrelius A, et al. Is there an altered steroid profile in patients with endometrial carcinoma? Cancer. 1993; 72(1): 173–181.
- Sznurkowski J, Knapp P, Bodnar L, et al. Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of endometrial cancer. Current Gynecologic Oncology. 2017; 15(1): 34–44.
- Krzakowski M, Herman K, Jassem J. Zalecenia postępowania diagnostyczno−terapeutycznego w nowotworach złośliwych, cz. 2. Via Medica, Gdańsk 2019: 243–247.
- Żyła ZG, Kinalska I. Ocena częstości występowania zespołu metabolicznego w populacji dorosłych mieszkańców gminy Tarnawa Dolna. Przegląd Kardiodiabetologiczny. 2010; 5(2): 93–97.
- Orekoya O, Samson ME, Trivedi T, et al. The Impact of Obesity on Surgical Outcome in Endometrial Cancer Patients: A Systematic Review. J Gynecol Surg. 2016; 32(3): 149–157.
- Santoso JT, Barton G, Riedley-Malone S, et al. Obesity and perioperative outcomes in endometrial cancer surgery. Arch Gynecol Obstet. 2012; 285(4): 1139–1144.
- Kerimoglu OS, Pekin A, Yilmaz SA, et al. Effect of the percentage of body fat on surgical, clinical and pathological outcomes in women with endometrial cancer. J Obstet Gynaecol Res. 2015; 41(3): 449–455.
- Jan S, Duquesne M, Marret H, et al. [Influence of Body Mass Index on management and prognosis of women with endometrial cancer]. Gynecol Obstet Fertil. 2014; 42(11): 766–771.
- Eisenhauer EL, Wypych KA, Mehrara BJ, et al. Comparing surgical outcomes in obese women undergoing laparotomy, laparoscopy, or laparotomy with panniculectomy for the staging of uterine malignancy. Ann Surg Oncol. 2007; 14(8): 2384–2391.
- Derossis AM, Fey JV, Cody HS, et al. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg. 2003; 197(6): 896–901.
- Li Sk, Zhou Yb, Zhou Cf, et al. [Influence of obesity on short-term surgical outcome in patients with gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2010; 13(2): 133–136.
- Gunderson CC, Java J, Moore KN, et al. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol. 2014; 133(1): 23–27.
- Bouwman F, Smits A, Lopes A, et al. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery--an institutional study and systematic review of the literature. Gynecol Oncol. 2015; 139(2): 369–376.
- Erkanli S, Kayaselçuk F, Bagis T, et al. Impact of morbid obesity in surgical management of endometrial cancer: surgical morbidity, clinical and pathological aspects. Eur J Gynaecol Oncol. 2006; 27(4): 401–404.
- Doyle SL, Lysaght J, Reynolds JV. Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev. 2010; 11(12): 875–886.
